HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Free Full Text (PDF) Free All Versions of this Article: fj.08-108043v1 22/10/3419    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Smith, E. L. Articles by Schuchman, E. H. Search for Related Content PubMed PubMed Citation Articles by Smith, E. L. Articles by Schuchman, E. H.

The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases

Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, New York, USA

¹Correspondence: Department of Genetics and Genomic Sciences, Mt. Sinai School of Medicine, 1425 Madison Ave., Rm. 14–20A, New York, NY 10029, USA. E-mail: edward.schuchman{at}mssm.edu

Acid sphingomyelinase (ASM; E.C. 3.1.4.12) is best known for its involvement in the lysosomal storage disorder Niemann-Pick disease (NPD). Through studies that began by investigating this rare disease, recent findings have uncovered the important role of this enzyme in the initiation of ceramide-mediated signal transduction. This unique function involves translocation of the enzyme from intracellular compartments to the outer leaflet of the cell membrane, where hydrolysis of sphingomyelin into ceramide initiates membrane reorganization and facilitates the formation and coalescence of lipid microdomains. These microdomains are sites of protein-protein interactions that lead to downstream signaling, and perturbation of microdomain formation influences the pathophysiology of many common diseases. The initial observations implicating ASM in this process have come from studies using cells from patients with NPD or from ASM knockout (ASMKO) mice, where the genetic deficiency of this enzymatic activity has been shown to protect these cells and animals from stress-induced and developmental apoptosis. This review will discuss the complex biology of this enzyme in the context of these new findings and its recently reported importance in common human diseases, including cancer, sepsis, cardiovascular, pulmonary, liver, and neurological diseases as well as the potential for using ASM (or ASM inhibitors) as therapeutic agents.—Smith, E. L., Schuchman, E. H. The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases.

Key Words: ceramide • human pathology • lysosomal enzyme

This article has been cited by other articles:

				R. Chen, A. E. Feldstein, and T. M. McIntyre Suppression of Mitochondrial Function by Oxidatively Truncated Phospholipids Is Reversible, Aided by Bid, and Suppressed by Bcl-XL J. Biol. Chem., September 25, 2009; 284(39): 26297 - 26308. [Abstract] [Full Text] [PDF]

				C. Pavoine and F. Pecker Sphingomyelinases: their regulation and roles in cardiovascular pathophysiology Cardiovasc Res, May 1, 2009; 82(2): 175 - 183. [Abstract] [Full Text] [PDF]